Touyun Biotech Group Limited (1332.HK)

HKD 0.18

(-7.22%)

Net Debt Summary of Touyun Biotech Group Limited

  • Touyun Biotech Group Limited's latest annual net debt in 2023 was 350.41 Million HKD , up 31.28% from previous year.
  • Touyun Biotech Group Limited's latest quarterly net debt in 2024 Q2 was 355.43 Million HKD , down 0.0% from previous quarter.
  • Touyun Biotech Group Limited reported annual net debt of 266.91 Million HKD in 2022, up 3.79% from previous year.
  • Touyun Biotech Group Limited reported annual net debt of 257.17 Million HKD in 2021, up 220.73% from previous year.
  • Touyun Biotech Group Limited reported quarterly net debt of 350.41 Million HKD for 2023 FY, up 31.28% from previous quarter.
  • Touyun Biotech Group Limited reported quarterly net debt of 327.46 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of Touyun Biotech Group Limited (2023 - 2011)

Historical Annual Net Debt of Touyun Biotech Group Limited (2023 - 2011)

Year Net Debt Net Debt Growth
2023 350.41 Million HKD 31.28%
2022 266.91 Million HKD 3.79%
2021 257.17 Million HKD 220.73%
2020 80.18 Million HKD -63.63%
2019 220.44 Million HKD 80.77%
2018 121.94 Million HKD 355.36%
2017 -47.75 Million HKD 75.39%
2016 -194.03 Million HKD -217.69%
2015 164.87 Million HKD 545.2%
2014 -37.03 Million HKD 54.0%
2013 -80.5 Million HKD -8.78%
2012 -74 Million HKD -23.76%
2011 -59.79 Million HKD 0.0%

Peer Net Debt Comparison of Touyun Biotech Group Limited

Name Net Debt Net Debt Difference
Starlite Holdings Limited -148.96 Million HKD 335.229%
Litu Holdings Limited -235.58 Million HKD 248.745%
Champion Alliance International Holdings Limited -100.49 Million HKD 448.673%
Huaxi Holdings Company Limited 12.05 Million HKD -2807.052%